Ignite Creation Date:
2025-12-25 @ 2:00 AM
Ignite Modification Date:
2026-01-31 @ 2:18 AM
Study NCT ID:
NCT04233294
Status:
RECRUITING
Last Update Posted:
2020-08-14
First Post:
2020-01-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Addition of Chidamide to the Combination Treatment of Decitabine Plus Camrelizumab in Combination Treatment Resistant/Relapsed Patients With Classical Hodgkin Lymphoma
Sponsor:
Chinese PLA General Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CHN-PLAGH-BT-045
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None